Evidence map›Paper›PMID 32504635›Full record

ArticleExperimental neurology2020

A novel fast-channel myasthenia caused by mutation in β subunit of AChR reveals subunit-specific contribution of the intracellular M1-M2 linker to channel gating.

Xin-Ming Shen, Li Di, Shelley Shen, Yuying Zhao, Ann M Neumeyer, Duygu Selcen, Steven M Sine, Andrew G Engel

Open access · greenAbstract readCase Reports
In one paragraph

Article in Experimental neurology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Xin-Ming ShenDepartment of Neurology and Neuromuscular Research Laboratory, Mayo Clinic, Rochester, MN, USA. Electronic address: shen.xinming@mayo.edu.
Li DiDepartment of Neurology and Neuromuscular Research Laboratory, Mayo Clinic, Rochester, MN, USA.
Shelley ShenDepartment of Neurology and Neuromuscular Research Laboratory, Mayo Clinic, Rochester, MN, USA.
Yuying ZhaoDepartment of Neurology and Neuromuscular Research Laboratory, Mayo Clinic, Rochester, MN, USA.
Ann M NeumeyerDepartment of Child Neurology, Massachusetts General Hospital for Children, Lexington, MA, USA.
Duygu SelcenDepartment of Neurology and Neuromuscular Research Laboratory, Mayo Clinic, Rochester, MN, USA.
Steven M SineDepartment of Physiology and Biomedical Engineering and Receptor Biology Laboratory, Mayo Clinic, Rochester, MN, USA; Department of Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA; Department of Neurology, Mayo Clinic, Rochester, MN, USA.
Andrew G EngelDepartment of Neurology and Neuromuscular Research Laboratory, Mayo Clinic, Rochester, MN, USA. Electronic address: age@mayo.edu.
Mayo Clinic in Florida · USMayo Clinic · USMassachusetts General Hospital · US

Funding

STRUCTURE/FUNCTION OF THE ACETYLCHOLINE RECEPTORR01NS031744 · NINDS · MAYO CLINIC ROCHESTER · PI SINE, STEVEN M · 1992 to 2023
$7.3M
Structure and Function of the Acetylcholine ReceptorR37NS031744 · NINDS · MAYO CLINIC ROCHESTER · PI SINE, STEVEN M · 2001 to 2007
$4.1M
Congenital Myasthenic SyndromesR01NS109491 · NINDS · MAYO CLINIC ROCHESTER · PI ENGEL, ANDREW GEORGE, SELCEN, DUYGU · 2019 to 2022
$1.8M
NINDS NIH HHS R01 NS031744NINDS NIH HHS R01 NS109491NINDS NIH HHS R37 NS031744
6 · The paper itself

Abstract

Genetic variants causing the fast-channel congenital myasthenic syndrome (CMS) have been identified in the α, δ, and ε but not the β subunit of acetylcholine receptor (AChR). A 16-year-old girl with severe myasthenia had low-amplitude and fast-decaying miniature endplate potentials. Mutation analysis revealed two heteroallelic variants in CHRNB1 encoding the AChR β subunit: a novel c.812C>T (p.P248L) variant in M1-M2 linker (p.P271L in HGVS nomenclature), and a ~430 bp deletion causing loss of exon 8 leading to frame-shift and a premature stop codon (p.G251Dfs*21). P248 is conserved in all β subunits of different species, but not in other AChR subunits. Measurements of radio-labeled α-bungarotoxin binding show that βP248L reduces AChR expression to 60% of wild-type. Patch clamp recordings of ACh-elicited single channel currents demonstrate that βP248L shortens channel opening bursts from 3.3 ms to 1.2 ms, and kinetic analyses predict that the decay of the synaptic response is accelerated 2.4-fold due to reduced probability of channel reopening. Substituting βP248 with threonine, alanine or glycine reduces the burst duration to 2.3, 1.7, and 1.5 ms, respectively. In non-β subunits, substituting leucine for residues corresponding to βP248 prolongs the burst duration to 4.5 ms in the α subunit, shortens it to 2.2 ms in the δ subunit, and has no effect in the ε subunit. Conversely, substituting proline for residues corresponding to βP248 prolongs the burst duration to 8.7 ms in the α subunit, to 4.6 ms in the δ subunit, but has no effect in the ε subunit. Thus, this fast channel CMS is caused by the dual defects of βP248L in reducing expression of the mutant receptor and accelerating the decay of the synaptic response. The results also reveal subunit-specific contributions of the M1-M2 linker to the durations of channel opening bursts.

Indexed as

AdolescentDNA Mutational AnalysisFemaleHumansIon Channel GatingMutationMyasthenic Syndromes, CongenitalReceptors, NicotinicCHRNB1 protein, humanReceptors, NicotinicAcetylchoine receptorChannel gatingCongenital myasthenic syndromesFast-channel myastheniaIntracellular linkerM1-M2 linkerNeuromuscular diseaseNeuromuscular junctionReceptor activationβ subunit

Identifiers

PMID32504635
PMCPMC7483818
OpenAlexW3033715835

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.